MENSTRUAL BLOOD STEM CELLS AS A POTENTIAL SUBSTRATE OF CELL THERAPY
S.V. Anisimov,1,2 V.I. Zemelko,1 T.M. Grinchuk,1,2 N.N. Nikolskiy 1,3
1 Institute of Cytology RAS, Saint-Petersburg; 2 V.A. Almazov Federal Center for Heart, Blood & Endocrinology, Saint-Petersburg;
3 Saint-Petersburg State Polytechnical University, Saint-Petersburg;
e-mail: askold5@hotmail.com
Cell replacement and restorative therapies have great perspectives in the treatment of various diseases and traumas. Various types of stem cells, most different in the
biological properties, are evaluated as the potential substrates of cell therapy for such diseases. Mesenchymal stem cells (MSC) possess relatively high proliferative activity
and high level of plasticity, and can be differentiated not only to the cells of the mesenchymal lineage, but also to the neurons. Among the MSC populations, a population of
endomentrial stem cells, including that present in the menstrual blood, is available most readily. In the current study, we analyze biological properties of the menstrual blood
stem cells and evaluate those cells as a potential substrate of cell therapy.
Key words: cell therapy, endometrial stem cells, menstrual blood stem cells
| Back
| Contents
| Main |
|
